Search Results - "TANA, Roberta"

Refine Results
  1. 1

    Metformin use and gynecological cancers: a novel treatment option emerging from drug repositioning by Gadducci, Angiolo, Biglia, Nicoletta, Tana, Roberta, Cosio, Stefania, Gallo, Martina

    Published in Critical reviews in oncology/hematology (01-09-2016)
    “…Highlights • Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added…”
    Get full text
    Journal Article
  2. 2

    Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer by Gadducci, Angiolo, Cosio, Stefania, Tana, Roberta, Genazzani, Andrea Riccardo

    Published in Critical reviews in oncology/hematology (01-01-2009)
    “…Abstract Tumour stage, residual disease after initial surgery, histological type and tumour grade are the most important clinical-pathological factors related…”
    Get full text
    Journal Article
  3. 3

    Treatment options in recurrent cervical cancer (Review) by GADDUCCI, ANGIOLO, TANA, ROBERTA, COSIO, STEFANIA, CIONINI, LUCA

    Published in Oncology letters (01-01-2010)
    “…The management of recurrent cervical cancer depends mainly on previous treatment and on the site and extent of recurrence. Concurrent cisplatin-based…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Molecular target therapies in endometrial cancer: From the basic research to the clinic by Gadducci, Angiolo, Tana, Roberta, Cosio, Stefania, Fanucchi, Antonio, Genazzani, Andrea Riccardo

    Published in Gynecological endocrinology (2008)
    “…Molecular targeted therapies represent an interesting field of pharmacological research in endometrial cancer. The loss of PTEN (phosphatase and tensin homolog…”
    Get full text
    Journal Article
  8. 8

    Brain Recurrences in Patients with Ovarian Cancer: Report of 12 Cases and Review of the Literature by GADDUCCI, Angiolo, TANA, Roberta, TETI, Giancarlo, FANUCCHI, Antonio, PASQUALETTI, Francesco, CIONINI, Luca, RICCARDO GENAZZANI, Andrea

    Published in Anticancer research (01-11-2007)
    “…The aim of the investigation was to assess 12 cases of brain recurrences among ovarian cancer patients who had undergone surgery followed by platinum-based…”
    Get full text
    Journal Article
  9. 9

    Novel insights on the malignant transformation of endometriosis into ovarian carcinoma by Gadducci, Angiolo, Lanfredini, Nora, Tana, Roberta

    Published in Gynecological endocrinology (01-09-2014)
    “…Abstract The malignant transformation of endometriosis is an uncommon event, which happens in 0.7-2.5% of the cases, and, when occurs, it usually involves the…”
    Get full text
    Journal Article
  10. 10

    Ovarian Cancer in Elderly Patients: Patterns of Care and Treatment Outcomes According to Age and Modified Frailty Index by Ferrero, Annamaria, Fuso, Luca, Tripodi, Elisa, Tana, Roberta, Daniele, Alberto, Zanfagnin, Valentina, Perotto, Stefania, Gadducci, Angiolo

    “…The present study assessed the predictive value of age and Modified Frailty Index (mFI) on the management of primary epithelial ovarian cancer (EOC) patients…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours by Gadducci, Angiolo, Lanfredini, Nora, Tana, Roberta

    Published in Gynecological endocrinology (01-07-2014)
    “…Abstract Malignant ovarian germ cell tumours (MOGCT) account for 5% of all ovarian malignancies. Their elevated chemosensitivity, the frequent unilaterality…”
    Get full text
    Journal Article
  14. 14

    The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature by Gadducci, Angiolo, Tana, Roberta, Cosio, Stefania, Genazzani, Andrea Riccardo

    Published in Critical reviews in oncology/hematology (01-04-2008)
    “…Abstract Pre-treatment serum squamous cell carcinoma antigen [SCC] levels are elevated in 28–88% of patients with squamous cell cervical cancer, and are…”
    Get full text
    Journal Article
  15. 15

    Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer by Laliscia, Concetta, Fabrini, Maria Grazia, Delishaj, Durim, Morganti, Riccardo, Greco, Carlo, Cantarella, Martina, Tana, Roberta, Paiar, Fabiola, Gadducci, Angiolo

    “…The objective of this study was to assess the role of stereotactic body radiotherapy (SBRT) in the treatment of distantly recurrent, oligometastatic…”
    Get more information
    Journal Article
  16. 16

    Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy by Gadducci, Angiolo, Cosio, Stefania, Fanucchi, Antonio, Tana, Roberta, Manacorda, Simona, Pistolesi, Sabina, Strigini, Francesca Letizia

    Published in Anticancer research (01-07-2016)
    “…To assess prognosis of gestational trophoblastic neoplasia (GTN) and obstetric outcome after chemotherapy. Sixty-six patients had diagnosis of hydatiform mole…”
    Get full text
    Journal Article
  17. 17

    Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva by Gadducci, Angiolo, Tana, Roberta, Barsotti, Cecilia, Guerrieri, Maria Elena, Genazzani, Andrea Riccardo

    Published in Critical reviews in oncology/hematology (01-07-2012)
    “…Abstract Several clinical–pathological parameters have been related to survival of patients with invasive squamous cell carcinoma of the vulva, whereas few…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Biochemical prognostic factors and risk of relapses in patients with cervical cancer by Gadducci, Angiolo, Tana, Roberta, Fanucchi, Antonio, Genazzani, Andrea Riccardo

    Published in Gynecologic oncology (01-10-2007)
    “…Abstract No validated tumor marker is currently available for the management of patients with cervical cancer. However, some tumor-associated antigens have…”
    Get full text
    Journal Article